Reducing Transfusion-transmitted Cytomegalovirus Infection by Providing Leukocyte-reduced Blood Products Donated by Low-risk Donors

被引：0
|
作者：
Shmookler, A. [1 ]
Losos, M. [1 ]
Scrape, S. [1 ]
Chen, J. [1 ]
机构：
[1] Ohio State Univ, Pathol, Columbus, OH 43210 USA
来源：
TRANSFUSION | 2016年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP426
引用
收藏
页码：191A / 192A
页数：2
相关论文
共 50 条
  • [31] Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan
    Taira, Rikizo
    Satake, Masahiro
    Momose, Shun'ya
    Hino, Satoru
    Suzuki, Yoshiharu
    Murokawa, Hiroyuki
    Uchida, Shigeharu
    Tadokoro, Kenji
    TRANSFUSION, 2013, 53 (07) : 1393 - 1404
  • [32] Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation
    Shigemura, Tomonari
    Yanagisawa, Ryu
    Komori, Kazutoshi
    Morita, Daisuke
    Kurata, Takashi
    Tanaka, Miyuki
    Sakashita, Kazuo
    Nakazawa, Yozo
    TRANSFUSION, 2019, 59 (10) : 3065 - 3070
  • [33] Transfusion-Transmitted Infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: A study of blood donors between 2017 and 2019
    Mremi, Alex
    Yahaya, James J.
    Nyindo, Mramba
    Mollel, Edson
    PLOS ONE, 2021, 16 (03):
  • [34] Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection
    Legler, TJ
    Riggert, J
    Simson, G
    Wolf, C
    Humpe, A
    Munzel, U
    Uy, A
    Köhler, M
    Heermann, KH
    TRANSFUSION, 2000, 40 (10) : 1192 - 1197
  • [35] The potential impact of implementing blood safety measures during an outbreak on transfusion-transmitted CHIKV infection risk
    Appassakij, H.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 409 - 409
  • [36] Risk of Transfusion-Transmitted Infection with Severe Acute Respiratory Syndrome Coronavirus 2 from Blood Donors in Japan (vol 64, pg 116, 2024)
    Shinohara, N.
    Ito, M.
    Kai, K.
    Kamo, N.
    Owada, T.
    Sobata, R.
    Yamagishi, N.
    Takahashi, H.
    Ikeda, Y.
    Sawai, H.
    Furuta, R. A.
    Matsubayashi, K.
    Hino, I
    Goto, N.
    Satake, M.
    TRANSFUSION, 2024, 64 (05) : 958 - 958
  • [37] Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk
    Lelie, Nico
    Busch, Michael
    Kleinman, Steven
    VIRUSES-BASEL, 2022, 14 (10):
  • [38] An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease
    Cervia, Joseph S.
    Sowemimo-Coker, Samuel O.
    Ortolano, Girolamo A.
    Wilkins, Karen
    Schaffer, Jeffrey
    Wortham, Samuel T.
    TRANSFUSION MEDICINE REVIEWS, 2006, 20 (03) : 190 - 206
  • [39] Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region
    Stolz, Martin
    Tinguely, Caroline
    Graziani, Mauro
    Fontana, Stefano
    Gowland, Peter
    Buser, Andreas
    Michel, Martine
    Canellini, Giorgia
    Zueger, Max
    Schumacher, Philippe
    Lelie, Nico
    Niederhauser, Christoph
    TRANSFUSION, 2010, 50 (12) : 2695 - 2706
  • [40] Risk of transfusion-transmitted malaria: evaluation of commercial ELISA kits for the detection of anti-Plasmodium antibodies in candidate blood donors
    Mangano, Valentina D.
    Perandin, Francesca
    Tiberti, Natalia
    Guerriero, Massimo
    Migliaccio, Franca
    Prato, Marco
    Bargagna, Lucia
    Tais, Stefano
    Degani, Monica
    Verra, Federica
    Bisoffi, Zeno
    Bruschi, Fabrizio
    MALARIA JOURNAL, 2019, 18 (1)
12345